These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6088828

  • 1. Improvement of cardiac performance by AR-L 115 BS, a new cardiotonic drug, in the experimental failing dog heart.
    Morita T, Satoh K, Taira N.
    Jpn Heart J; 1984 May; 25(3):439-45. PubMed ID: 6088828
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.
    Morita T, Satoh K, Taira N.
    Jpn Heart J; 1984 May; 25(3):447-60. PubMed ID: 6088829
    [Abstract] [Full Text] [Related]

  • 3. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
    Goto T, Nunoki K, Satoh K, Taira N.
    Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
    [Abstract] [Full Text] [Related]

  • 4. Improvement by trapidil of cardiac function of the dog heart-lung preparation depressed by pentobarbital.
    Satoh K, Kawada M, Taira N.
    Jpn Heart J; 1983 May; 24(3):399-405. PubMed ID: 6876384
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC, Roebel LE, Hsieh CP, Woodward JK.
    J Cardiovasc Pharmacol; 1984 May; 6(1):35-42. PubMed ID: 6199609
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
    Satoh K, Nunoki K, Goto T, Hosono M, Hashimoto H, Sato Y, Taira N.
    Jpn J Pharmacol; 1988 Jun; 47(2):189-95. PubMed ID: 3199595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
    Hauf GF, Bubenheimer P, Roskamm H.
    Arzneimittelforschung; 1981 Jun; 31(1a):253-6. PubMed ID: 7195235
    [Abstract] [Full Text] [Related]

  • 13. Effects of a new cardiotonic phosphodiesterase III inhibitor, olprinone, on cardiohemodynamics and plasma hormones in conscious pigs with heart failure.
    Adachi H, Tanaka H.
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):763-71. PubMed ID: 9234657
    [Abstract] [Full Text] [Related]

  • 14. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005.
    Dundore RL, Pagani ED, Bode DC, Bacon ER, Singh B, Lesher GY, Buchholz RA, Silver PJ.
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The effect of the benzimidazole derivative AR-L 115 BS on the activities of myocardial adenylate cyclase and phosphodiesterase preparations (author's transl)].
    Schuhmacher P, Greeff K, Noack E.
    Arzneimittelforschung; 1982 Jan; 32(1):80-2. PubMed ID: 6277343
    [Abstract] [Full Text] [Related]

  • 18. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff H.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals.
    Alousi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA.
    J Cardiovasc Pharmacol; 1983 Jul; 5(5):792-803. PubMed ID: 6195467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.